Informa plc (LON:INF) Stock Has Consensus Target Price of GBX 1,160 According to Analysts

Informa plc (LON:INF) has received an average rating of “Buy” from the six ratings firms that are covering the company, MarketBeat.com reports. Six analysts have rated the stock with a buy rating. The average 1-year target price among brokers that have covered the stock in the last year is GBX 1,160.

INF has been the subject of several analyst reports. Berenberg Bank restated a “buy” rating and issued a GBX 1,040 price objective on shares of Informa in a report on Thursday, October 8th. Deutsche Bank Aktiengesellschaft upped their target price on Informa from GBX 1,140 to GBX 1,290 and gave the stock a “buy” rating in a report on Friday, October 9th. Citigroup increased their price target on Informa from GBX 990 to GBX 1,090 and gave the company a “buy” rating in a research report on Wednesday, August 12th. Finally, JPMorgan Chase & Co. reduced their price target on Informa from GBX 1,300 to GBX 1,285 and set an “overweight” rating for the company in a research report on Thursday, July 2nd.

Informa Price Performance

Shares of INF stock opened at GBX 882.55 on Wednesday. The firm’s fifty day moving average price is GBX 890.68 and its two-hundred day moving average price is GBX 858.08. The company has a current ratio of 0.55, a quick ratio of 1.70 and a debt-to-equity ratio of 64.99. Informa has a 1 year low of GBX 719 and a 1 year high of GBX 1,000. The firm has a market capitalization of £11.03 billion, a P/E ratio of 51.61, a PEG ratio of 0.75 and a beta of 0.71.

Informa (LON:INF) last posted its quarterly earnings data on Thursday, July 30th. The company reported GBX 26.70 EPS for the quarter. Informa had a net margin of 5.43% and a return on equity of 3.90%. On average, equities analysts predict that Informa will post 59.32 EPS for the current fiscal year.

About Informa

Our events, digital products and academic research services connect specialists with knowledge, helping them learn more, know more and do more.

We do this in dozens of specialist markets and subject matter categories, including in Healthcare & Pharma, Technology, Finance, Education, Marketing, Health & Nutrition, Foodservice, and many more.

And we do this through a range of products and services, including major live events, specialist media and content, expert research articles, books and open research platforms, accredited training, buyer discovery services, and digital demand and lead-generation services.